As an Amazon Associate I earn from qualifying purchases from

Pfizer Remembers One other Blood Stress Medicine

April 25, 2022

The pharmaceutical firm Pfizer has voluntary recalled a blood stress medicine for the second time in a month.

Pfizer is recalling 5 a lot of blood stress medication Accupril due to elevated ranges of a nitrosamine, Nnitroso-quinapril, the corporate mentioned in a information launch posted Friday on the FDA web site.

Nitrosamines are present in water and meals, together with grilled meats and dairy merchandise, however impurities could improve an individual’s most cancers threat over lengthy durations of time, Pfizer mentioned.

Accupril is used to decrease blood stress and handle coronary heart failure. Pfizer mentioned it has not obtained any reviews of hostile reactions by individuals taking the drug.

“Pfizer believes the profit/threat profile of the merchandise stays constructive based mostly on at present obtainable information. Though long-term ingestion of Nnitroso-quinapril could also be related to a possible elevated most cancers threat in people, there isn’t a fast threat to sufferers taking this medicine,” the corporate mentioned.

The Accupril tables are bought in 10-, 20- and 40-mg doses. The affected lot numbers are DR9639, DX8682, DG1188, DX6031, and CK6260.

Sufferers taking the product ought to discuss to their physician. Sufferers with the affected product ought to name 888-345-0481.

Pfizer recalled one other blood stress medicine on March 22.

The affected merchandise in that recall are quinapril HCl/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, and two approved generics, quinapril plus hydrochlorothiazide and quinapril HCl/hydrochlorothiazide, distributed by Greenstone. The recall is over greater than accepted ranges of N-nitroso-quinapril, a compound generally known as a nitrosamine.

We will be happy to hear your thoughts

Leave a reply

Enable registration in settings - general
Compare items
  • Total (0)
Shopping cart